BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 1863073)

  • 21. L-tryptophan induced eosinophilia-myalgia syndrome.
    Chartash EK; Given WP; Vishnubhakat SM; Susin M; Coffey EL; Farmer PM; Albanese JM; Kaplan MH; Furie RA
    J Rheumatol; 1990 Nov; 17(11):1527-33. PubMed ID: 2273498
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Scleroderma-like fasciitis without eosinophilia after L-tryptophan ingestion.
    Schlessel K; Greenwald R; Hirschfield L
    J Rheumatol; 1991 May; 18(5):779-82. PubMed ID: 1865433
    [TBL] [Abstract][Full Text] [Related]  

  • 23. L-tryptophan implicated in human eosinophilia-myalgia syndrome causes fasciitis and perimyositis in the Lewis rat.
    Crofford LJ; Rader JI; Dalakas MC; Hill RH; Page SW; Needham LL; Brady LS; Heyes MP; Wilder RL; Gold PW
    J Clin Invest; 1990 Nov; 86(5):1757-63. PubMed ID: 2243145
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Eosinophilia-myalgia syndrome in association with L-tryptophan ingestion.
    Gresh JP; Vasey FB; Espinoza LR; Adelman HM; Germain BF
    J Rheumatol; 1990 Nov; 17(11):1557-8. PubMed ID: 2273503
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Eosinophilia-myalgia syndrome and L-tryptophan intake].
    von Gizycki-Nienhaus B; Meurer M; Krieg T; Braun-Falco O
    Hautarzt; 1991 Mar; 42(3):179-82. PubMed ID: 1829070
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Environmental pathology. Mast cell and eosinophil infiltration in intestinal mucosa of Lewis rats treated with L-tryptophan implicated in human eosinophilia myalgia syndrome.
    DeSchryver-Kecskemeti K; Gramlich TL; Crofford LJ; Rader JI; Page SW; Needham LL; Hill RH; Sternberg EM
    Mod Pathol; 1991 May; 4(3):354-7. PubMed ID: 2068062
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Eosinophilic fasciitis in children frequently progresses to scleroderma-like cutaneous fibrosis.
    Farrington ML; Haas JE; Nazar-Stewart V; Mellins ED
    J Rheumatol; 1993 Jan; 20(1):128-32. PubMed ID: 8441144
    [TBL] [Abstract][Full Text] [Related]  

  • 28. L-tryptophan-related eosinophilia-myalgia syndrome: a case report.
    Wong CB; Love J; Pon E; Scottolini AG; Manoukian AA
    Hawaii Med J; 1990 Aug; 49(8):295-8, 303. PubMed ID: 2211094
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The clinical spectrum of the eosinophilia-myalgia syndrome associated with L-tryptophan ingestion. Clinical features in 20 patients and aspects of pathophysiology.
    Martin RW; Duffy J; Engel AG; Lie JT; Bowles CA; Moyer TP; Gleich GJ
    Ann Intern Med; 1990 Jul; 113(2):124-34. PubMed ID: 2360751
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Eosinophilia-myalgia syndrome after L-tryptophan intake].
    Zillikens D; Bammel A; Lurz C; Elsner P; Burg G
    Hautarzt; 1991 Mar; 42(3):154-7. PubMed ID: 2055764
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A case of the eosinophilia-myalgia syndrome].
    Ishikawa A; Akahosi T; Okada J; Kondo H; Kasiwazaki S
    Ryumachi; 1992 Aug; 32(4):327-30; discussion 330-2. PubMed ID: 1411794
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of the eosinophilia-myalgia syndrome with the ingestion of tryptophan.
    Hertzman PA; Blevins WL; Mayer J; Greenfield B; Ting M; Gleich GJ
    N Engl J Med; 1990 Mar; 322(13):869-73. PubMed ID: 2314421
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An eosinophilia-myalgia syndrome associated with an L-tryptophan containing product.
    Saag KG; Goldschmidt R; Vernof H; Golbus J
    J Rheumatol; 1990 Nov; 17(11):1551-3. PubMed ID: 2273501
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term follow-up of patients with diffuse fasciitis and eosinophilia associated with L-tryptophan ingestion.
    Beko E; Pervaiz S; Nanda V; Dhawan S
    Cutis; 1993 Apr; 51(4):266-70. PubMed ID: 8477608
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An investigation of the cause of the eosinophilia-myalgia syndrome associated with tryptophan use.
    Belongia EA; Hedberg CW; Gleich GJ; White KE; Mayeno AN; Loegering DA; Dunnette SL; Pirie PL; MacDonald KL; Osterholm MT
    N Engl J Med; 1990 Aug; 323(6):357-65. PubMed ID: 2370887
    [TBL] [Abstract][Full Text] [Related]  

  • 36. L-tryptophan-associated eosinophilia-myalgia syndrome: perspective of a new illness.
    Kaufman LD; Seidman RJ
    Rheum Dis Clin North Am; 1991 May; 17(2):427-41. PubMed ID: 1862249
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Eosinophilic fasciitis--current knowledge].
    Wojas-Pelc A; Wielowieyska-SzybiƄska D; Lipko-Godlewska S
    Przegl Lek; 2003; 60(2):116-9. PubMed ID: 12939859
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Case 4-1990: eosinophilic fasciitis.
    Gorn A
    N Engl J Med; 1990 Mar; 322(13):931. PubMed ID: 2314428
    [No Abstract]   [Full Text] [Related]  

  • 39. Cutaneous mucinosis in a patient with eosinophilia-myalgia syndrome associated with L-tryptophan ingestion.
    Dubin DB; Kwan TH; Morse MO; Case DC
    Arch Dermatol; 1990 Nov; 126(11):1517-8. PubMed ID: 2241210
    [No Abstract]   [Full Text] [Related]  

  • 40. L-tryptophan-associated eosinophilic fasciitis prior to the 1989 eosinophilia-myalgia syndrome outbreak.
    Hibbs JR; Mittleman B; Hill P; Medsger TA
    Arthritis Rheum; 1992 Mar; 35(3):299-303. PubMed ID: 1536667
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.